N Awofeso
This paper discusses a model for optimising the screening of prison inmates, and vaccinating them against hepatitis B infection. Hepatitis B and other blood borne infections are common in prison populations worldwide because of previous or current intravenous drug use and unprotected sexual intercourse. Preliminary Ž findings from the implementation of the model described in New SouthWales prison settings highlight its signiŽficant potential for enhancing clinical accountability, as well as improving systems for vaccinating prison inmates. It is however inadequate for optimising sero-conversion, or vaccination follow-up, rates.Such aspects require concurrent adoption of complementary models.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi